John S. King, MD » SRH PPCNVM POHS Subretinal TPA

Jan 9 2019 by John S. King, MD

76-year-old white male with history of treat/extend with Eylea OD for a PPCNVM; also monocular due to large scar in fellow eye. Two months since last injection, had acute decrease in vision OD and was seen that day. Vision CF; moderate SRH involving the fovea. Discussed monotherapy with anti-VEGF vs displacement, and elected for PPV, srTPA, AFx, SF6. Total of 0.2 cc of 25 microgram/0.1 ml of srTPA administered from two different areas in the temporal macula.

Photographer: Stacey Coleman

Imaging device: Topcon 50

Condition/keywords: choroidal neovascular membrane (CNVM), ocular histoplasmosis syndrome (OHS), peripapillary hemorrhage

Jan 9 2019 by John S. King, MD

76-year-old white male with history of treat/extend with Eylea OD for a PPCNVM; also monocular due to large scar in fellow eye. Two months since last injection, had acute decrease in vision OD and was seen that day. Vision CF; moderate SRH involving the fovea. Discussed monotherapy with anti-VEGF vs displacement, and elected for PPV, srTPA, AFx, SF6. Total of 0.2 cc of 25 microgram/0.1 ml of srTPA administered from two different areas in the temporal macula. 10 days post-op vision is improving; 20/200 J7; displacement of heme (photo)

Photographer: Kay Dalby

Imaging device: Topcon 50

Condition/keywords: choroidal neovascular membrane (CNVM), peripapillary hemorrhage, presumed ocular histoplasmosis syndrome (POHS)

Jan 9 2019 by John S. King, MD

76-year-old white male with history of treat/extend with Eylea OD for a PPCNVM; also monocular due to large scar in fellow eye. Two months since last injection, had acute decrease in vision OD and was seen that day. Vision CF; moderate SRH involving the fovea. Discussed monotherapy with anti-VEGF vs displacement, and elected for PPV, srTPA, AFx, SF6. Total of 0.2 cc of 25 microgram/0.1 ml of srTPA administered from two different areas in the temporal macula. This is the pre and post-op OCTs. The right image shows decreased SRF/H with improved foveal foveal contour.

Imaging device: Topcan 50

Condition/keywords: presumed ocular histoplasmosis syndrome (POHS)